IDO2 and long COVID-19: Recent research findings suggest that the brain tissue of patients with PASC exhibits a significant expression of indoleamine 2, 3-dioxygenase-2 (IDO2), which plays a role in modulating SARS-CoV-2 infection through autophagy and apoptosis (27).